Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma

Recurrent CNS lymphoma continues to be associated with poor outcomes in the rituximab era. Although IV rituximab mediates superior disease control of systemic non-Hodgkin lymphoma (NHL), it fails to completely eliminate the risk of meningeal recurrence, likely due to minimal CNS penetration. Given t...

詳細記述

保存先:
書誌詳細
主要な著者: Rubenstein, James L., Li, Jing, Chen, Lingjing, Advani, Ranjana, Drappatz, Jan, Gerstner, Elizabeth, Batchelor, Tracy, Krouwer, Hendrikus, Hwang, James, Auerback, Glenna, Kadoch, Cigall, Lowell, Clifford, Munster, Pamela, Cha, Soonmee, Shuman, Marc A., Damon, Lloyd E.
フォーマット: Artigo
言語:Inglês
出版事項: American Society of Hematology 2013
主題:
Clinical Trials and Observations
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3563362/
https://ncbi.nlm.nih.gov/pubmed/23197589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-07-440974
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料